These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 18222570)

  • 1. NSAIDs revisited: putative molecular basis of their interactions with peroxisome proliferator-activated gamma receptor (PPARgamma).
    Romeiro NC; Sant'Anna CM; Lima LM; Fraga CA; Barreiro EJ
    Eur J Med Chem; 2008 Sep; 43(9):1918-25. PubMed ID: 18222570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indol-1-yl acetic acids as peroxisome proliferator-activated receptor agonists: design, synthesis, structural biology, and molecular docking studies.
    Mahindroo N; Wang CC; Liao CC; Huang CF; Lu IL; Lien TW; Peng YH; Huang WJ; Lin YT; Hsu MC; Lin CH; Tsai CH; Hsu JT; Chen X; Lyu PC; Chao YS; Wu SY; Hsieh HP
    J Med Chem; 2006 Feb; 49(3):1212-6. PubMed ID: 16451087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of peroxisome proliferator activated receptor γ regulation by non-steroidal anti-inflammatory drugs.
    Puhl AC; Milton FA; Cvoro A; Sieglaff DH; Campos JC; Bernardes A; Filgueira CS; Lindemann JL; Deng T; Neves FA; Polikarpov I; Webb P
    Nucl Recept Signal; 2015; 13():e004. PubMed ID: 26445566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural insight into PPARgamma activation through covalent modification with endogenous fatty acids.
    Waku T; Shiraki T; Oyama T; Fujimoto Y; Maebara K; Kamiya N; Jingami H; Morikawa K
    J Mol Biol; 2009 Jan; 385(1):188-99. PubMed ID: 18977231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based drug design of a novel family of PPARgamma partial agonists: virtual screening, X-ray crystallography, and in vitro/in vivo biological activities.
    Lu IL; Huang CF; Peng YH; Lin YT; Hsieh HP; Chen CT; Lien TW; Lee HJ; Mahindroo N; Prakash E; Yueh A; Chen HY; Goparaju CM; Chen X; Liao CC; Chao YS; Hsu JT; Wu SY
    J Med Chem; 2006 May; 49(9):2703-12. PubMed ID: 16640330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flexible ligand recognition of peroxisome proliferator-activated receptor-gamma (PPARgamma).
    Yamagishi K; Yamamoto K; Mochizuki Y; Nakano T; Yamada S; Tokiwa H
    Bioorg Med Chem Lett; 2010 Jun; 20(11):3344-7. PubMed ID: 20444603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational screening of phthalate monoesters for binding to PPARgamma.
    Kaya T; Mohr SC; Waxman DJ; Vajda S
    Chem Res Toxicol; 2006 Aug; 19(8):999-1009. PubMed ID: 16918238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand-induced stabilization and activation of peroxisome proliferator-activated receptor gamma.
    Gani OA; Sylte I
    Chem Biol Drug Des; 2008 Jul; 72(1):50-7. PubMed ID: 18554251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The differential interactions of peroxisome proliferator-activated receptor gamma ligands with Tyr473 is a physical basis for their unique biological activities.
    Einstein M; Akiyama TE; Castriota GA; Wang CF; McKeever B; Mosley RT; Becker JW; Moller DE; Meinke PT; Wood HB; Berger JP
    Mol Pharmacol; 2008 Jan; 73(1):62-74. PubMed ID: 17940191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indenone derivatives: a novel template for peroxisome proliferator-activated receptor gamma (PPARgamma) agonists.
    Ahn JH; Shin MS; Jung SH; Kang SK; Kim KR; Rhee SD; Jung WH; Yang SD; Kim SJ; Woo JR; Lee JH; Cheon HG; Kim SS
    J Med Chem; 2006 Jul; 49(15):4781-4. PubMed ID: 16854085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPARgamma as a new therapeutic target in inflammatory bowel diseases.
    Dubuquoy L; Rousseaux C; Thuru X; Peyrin-Biroulet L; Romano O; Chavatte P; Chamaillard M; Desreumaux P
    Gut; 2006 Sep; 55(9):1341-9. PubMed ID: 16905700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New 2-aryloxy-3-phenyl-propanoic acids as peroxisome proliferator-activated receptors alpha/gamma dual agonists with improved potency and reduced adverse effects on skeletal muscle function.
    Fracchiolla G; Laghezza A; Piemontese L; Tortorella P; Mazza F; Montanari R; Pochetti G; Lavecchia A; Novellino E; Pierno S; Conte Camerino D; Loiodice F
    J Med Chem; 2009 Oct; 52(20):6382-93. PubMed ID: 19775169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel PPAR-gamma agonists identified from a natural product library: a virtual screening, induced-fit docking and biological assay study.
    Salam NK; Huang TH; Kota BP; Kim MS; Li Y; Hibbs DE
    Chem Biol Drug Des; 2008 Jan; 71(1):57-70. PubMed ID: 18086153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of (beta-carboxyethyl)-rhodanine derivatives exhibiting peroxisome proliferator-activated receptor gamma activity.
    Choi J; Ko Y; Lee HS; Park YS; Yang Y; Yoon S
    Eur J Med Chem; 2010 Jan; 45(1):193-202. PubMed ID: 19879669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The many faces of PPARgamma: anti-inflammatory by any means?
    Szanto A; Nagy L
    Immunobiology; 2008; 213(9-10):789-803. PubMed ID: 18926294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential backbone assignment of peroxisome proliferator-activated receptor-gamma ligand binding domain.
    Riepl H; Hartl R; Bauer M; Nar H; Kauschke SG; Kalbitzer HR; Maurer T
    J Biomol NMR; 2005 Jul; 32(3):259. PubMed ID: 16132831
    [No Abstract]   [Full Text] [Related]  

  • 17. Rational design of a pirinixic acid derivative that acts as subtype-selective PPARgamma modulator.
    Thieme TM; Steri R; Proschak E; Paulke A; Schneider G; Schubert-Zsilavecz M
    Bioorg Med Chem Lett; 2010 Apr; 20(8):2469-73. PubMed ID: 20307981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and structural analysis of phenylpropanoic acid-type PPARγ-selective agonists: discovery of reversed stereochemistry-activity relationship.
    Ohashi M; Oyama T; Nakagome I; Satoh M; Nishio Y; Nobusada H; Hirono S; Morikawa K; Hashimoto Y; Miyachi H
    J Med Chem; 2011 Jan; 54(1):331-41. PubMed ID: 21128600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies for the labeling of halogen-substituted peroxisome proliferator-activated receptor gamma ligands: potential positron emission tomography and single photon emission computed tomography imaging agents.
    Lee BC; Lee KC; Lee H; Mach RH; Katzenellenbogen JA
    Bioconjug Chem; 2007; 18(2):514-23. PubMed ID: 17315977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor gamma as a novel therapeutic target in asthma.
    Park SJ; Lee YC
    J Asthma; 2008; 45(1):1-8. PubMed ID: 18259989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.